FY2025 Earnings Forecast for PAHC Issued By Zacks Research

Phibro Animal Health Co. (NASDAQ:PAHC) – Zacks Research raised their FY2025 earnings estimates for shares of Phibro Animal Health in a report issued on Wednesday, March 12th. Zacks Research analyst R. Department now forecasts that the company will earn $1.91 per share for the year, up from their prior estimate of $1.87. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share.

A number of other analysts have also recently weighed in on PAHC. StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Saturday. Morgan Stanley raised their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Finally, Barclays raised their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research note on Monday, February 10th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $21.00.

Phibro Animal Health Stock Down 1.1 %

Shares of NASDAQ:PAHC opened at $21.62 on Monday. The stock has a market cap of $875.67 million, a P/E ratio of 45.04, a P/E/G ratio of 0.45 and a beta of 0.58. The firm has a fifty day moving average price of $22.62 and a 200 day moving average price of $22.59. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. Phibro Animal Health has a 1-year low of $12.07 and a 1-year high of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.22%. Phibro Animal Health’s dividend payout ratio is presently 100.00%.

Hedge Funds Weigh In On Phibro Animal Health

A number of large investors have recently made changes to their positions in PAHC. Vanguard Group Inc. increased its holdings in Phibro Animal Health by 1.4% during the 4th quarter. Vanguard Group Inc. now owns 1,514,736 shares of the company’s stock valued at $31,809,000 after acquiring an additional 20,604 shares in the last quarter. American Century Companies Inc. lifted its position in Phibro Animal Health by 18.0% during the fourth quarter. American Century Companies Inc. now owns 635,599 shares of the company’s stock valued at $13,348,000 after buying an additional 96,787 shares in the last quarter. Nuveen Asset Management LLC lifted its position in Phibro Animal Health by 21.4% during the fourth quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company’s stock valued at $12,348,000 after buying an additional 103,618 shares in the last quarter. Renaissance Technologies LLC lifted its position in Phibro Animal Health by 1.9% during the fourth quarter. Renaissance Technologies LLC now owns 557,800 shares of the company’s stock valued at $11,714,000 after buying an additional 10,600 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in Phibro Animal Health by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 515,979 shares of the company’s stock valued at $10,838,000 after buying an additional 8,510 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.